Nova Eye Medical Stock Price To Sales
EYE Stock | 0.18 0.02 12.50% |
Nova Eye Medical fundamentals help investors to digest information that contributes to Nova Eye's financial success or failures. It also enables traders to predict the movement of Nova Stock. The fundamental analysis module provides a way to measure Nova Eye's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nova Eye stock.
Nova | Price To Sales |
Nova Eye Medical Company Price To Sales Analysis
Nova Eye's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Nova Eye Price To Sales | 1.72 X |
Most of Nova Eye's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nova Eye Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition |
Based on the latest financial disclosure, Nova Eye Medical has a Price To Sales of 1.7187 times. This is 91.97% lower than that of the Health Care Equipment & Supplies sector and 64.04% lower than that of the Health Care industry. The price to sales for all Australia stocks is 84.95% higher than that of the company.
Nova Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nova Eye's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nova Eye could also be used in its relative valuation, which is a method of valuing Nova Eye by comparing valuation metrics of similar companies.Nova Eye is currently under evaluation in price to sales category among its peers.
Nova Fundamentals
Return On Equity | -0.39 | ||||
Return On Asset | -0.19 | ||||
Profit Margin | (0.38) % | ||||
Operating Margin | (0.26) % | ||||
Current Valuation | 38.43 M | ||||
Shares Outstanding | 229.07 M | ||||
Shares Owned By Insiders | 18.59 % | ||||
Shares Owned By Institutions | 18.74 % | ||||
Price To Book | 1.93 X | ||||
Price To Sales | 1.72 X | ||||
Revenue | 23.32 M | ||||
Gross Profit | 14.39 M | ||||
EBITDA | (5.98 M) | ||||
Net Income | (8.79 M) | ||||
Cash And Equivalents | 7.42 M | ||||
Total Debt | 3.35 M | ||||
Book Value Per Share | 0.09 X | ||||
Cash Flow From Operations | (7.73 M) | ||||
Earnings Per Share | (0.04) X | ||||
Target Price | 0.59 | ||||
Beta | 0.96 | ||||
Market Capitalization | 40.09 M | ||||
Total Asset | 29.88 M | ||||
Retained Earnings | (30.69 M) | ||||
Working Capital | 9.07 M | ||||
Net Asset | 29.88 M |
About Nova Eye Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nova Eye Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Eye using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Eye Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nova Stock Analysis
When running Nova Eye's price analysis, check to measure Nova Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Eye is operating at the current time. Most of Nova Eye's value examination focuses on studying past and present price action to predict the probability of Nova Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Eye's price. Additionally, you may evaluate how the addition of Nova Eye to your portfolios can decrease your overall portfolio volatility.